XRD analysis in forensic drug investigation using benchtop ARL EQUINOX 100 X-ray Diffractometer

Significance of the Topic

Modern forensic investigations require rapid and reliable identification of illicit drugs to trace provenance, confirm active ingredients and support legal evidence. X-ray diffraction (XRD) complements existing techniques by providing crystallographic information that distinguishes polymorphs, salts and excipients within powdered and bulk samples.

Objectives and Overview

This application note demonstrates how benchtop XRD using the ARL EQUINOX 100 addresses three critical forensic questions:

• Confirmation of preliminary findings from complementary methods such as mass spectrometry
• Differentiation of chemical forms (e.g., base vs. hydrochloride hydrate)
• Identification and quantification of main and secondary phases for sample comparison and clustering

Methodology

Powdered drug samples provided by forensic authorities were analyzed in reflection mode on the ARL EQUINOX 100 using Cu Kα radiation. Data acquisition was performed in a 10-minute scan per sample.

Instrumental Setup

• Instrument: Thermo Scientific ARL EQUINOX 100 benchtop diffractometer
• X-ray source: 50 W micro-focus tube (Cu) with mirror optics, no external chiller required
• Detector: Curved position sensitive detector (CPS) for simultaneous peak capture
• Software and databases: MDI JADE 2010 with ICDD PDF-4 Organics

Key Results and Discussion

• Heroin Analysis: XRD patterns clearly identified heroin hydrochloride monohydrate, confirming the presence of the salt hydrate form and absence of diluents, which implies non-distribution grade sample.
• Cocaine Blends: Two cocaine hydrochloride samples showed different dilution profiles. Sample 1 contained approximately 35 wt% cocaine with α-lactose and caffeine, while Sample 2 exceeded 90 wt% cocaine, demonstrating rapid quantification of active content and excipient phases.

Benefits and Practical Applications

XRD analysis on the EQUINOX 100 enables forensic labs to:

• Confirm chemical identity and crystalline form in under 10 minutes
• Quantify active ingredients and excipients via Rietveld refinement
• Support chain-of-custody and sample provenance through phase fingerprinting
• Deploy a portable, bench-top solution without extensive infrastructure

Future Trends and Potential Applications

Advances may include integration of automated sample handlers, enhanced micro-focus sources for trace analysis, machine-learning-driven phase identification and field-deployable platforms for on-site drug screening and environmental forensics.

Conclusion

The benchtop ARL EQUINOX 100 XRD system delivers rapid, reliable qualitative and quantitative phase analysis of drug-related samples. Its combination of high-brightness source, CPS detector and comprehensive software enables forensic experts to confirm compound identity, hydrate forms and excipient content, facilitating sample tracing and evidentiary support.